amlodipine has been researched along with ag-490 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
| Fan, H; Liu, Z; Luo, W; Ouyang, F; Tang, L; Yan, Y; Yang, H; Yuan, W | 1 |
1 review(s) available for amlodipine and ag-490
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
1 trial(s) available for amlodipine and ag-490
| Article | Year |
|---|---|
Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based on the JAK/STAT pathway.
Topics: Aged; Amlodipine; Animals; Atorvastatin; Essential Hypertension; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Janus Kinases; Rats; Rats, Inbred SHR; Signal Transduction; STAT Transcription Factors | 2023 |